Xtx Topco LTD Immatics N.V. Transaction History

Xtx Topco LTD

$1.12 Billion
Q2 2024

A detailed history of Xtx Topco LTD transactions in Immatics N.V. stock. As of the latest transaction made, Xtx Topco LTD holds 27,587 shares of IMTX stock, worth $349,803. This represents 0.03% of its overall portfolio holdings.

Number of Shares

27,587

Holding current value

$349,803

% of portfolio

0.03%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 12, 2024	BUY	$9.78 - $13.49 $269,800 - $372,148	27,587 New	27,587 $320,000
Q4 2022 Feb 14, 2023	BUY	$8.05 - $11.58 $97,960 - $140,917	12,169 New	12,169 $105,000

Others Institutions Holding IMTX

# of Institutions

Shares Held

76.6M

Call Options Held

571K

Put Options Held

210K

Rtw Investments, LP New York, NY

10M
Shares

$127 Million
1.94% of portfolio
Wellington Management Group LLP Boston, MA

9.54M
Shares

$121 Million
0.02% of portfolio
Perceptive Advisors LLC New York, NY

8.09M
Shares

$103 Million
2.72% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

7.43M
Shares

$94.3 Million
0.05% of portfolio
Baker Bros. Advisors LP New York, NY

6.44M
Shares

$81.7 Million
1.0% of portfolio

View Full List

About Immatics N.V.

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $967M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

More about IMTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account